Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 107, Issue 2, 2009, Pages

  Alons, Kai ^a,b   Kuijpers, Sophie C C ^a   Jong, Edo de ^a   van Merkesteyn, J P Richard ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; CLODRONIC ACID; PAMIDRONIC ACID;

ADULT; AGED; ARTICLE; BONE NECROSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; CLINICAL PROTOCOL; DEBRIDEMENT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAW DISEASE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; OSTEOMYELITIS; RETROSPECTIVE STUDY; TOOTH EXTRACTION; TOOTH IMPLANTATION;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; BONE DENSITY CONSERVATION AGENTS; CHRONIC DISEASE; CLINICAL PROTOCOLS; CLODRONIC ACID; DEBRIDEMENT; DENTAL IMPLANTS; DIPHOSPHONATES; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; JAW DISEASES; MIDDLE AGED; OSTEOMYELITIS; OSTEONECROSIS; RETROSPECTIVE STUDIES; TOOTH EXTRACTION;

EID: 58149291683     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2008.09.021     Document Type: Article

References (23)

1. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 (2003) 1238-1239
2. Ruggiero S.L., Fantasia J., and Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 433-441
3. Zavras A.I., and Zhu S. Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?. J Oral Maxillofac Surg 64 (2006) 917-923
4. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65 (2007) 369-376
5. Migliorati C.A., Siegel M.A., and Elting L.S. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 7 (2006) 447-449
6. Marx R.E., Sawatari Y., Fortin M., and Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac surg 63 (2005) 1567-1575
7. Migliorati C.A., Schubert M.M., Peterson D.E., and Seneda L.M. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104 (2005) 83-93
8. Badros A., Weikel D., Salama A., Goloubeva O., Schneider A., Rapoport A., et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 24 (2006) 9542
9. Dimopoulos M.A., Kastritis E., Anagnostopoulos A., Melakopoulos I., Gika D., Moulopoulos L.A., et al. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Haematologica 91 (2006) 968-971
10. Elad S., Yarom N., Hamed W., Ayalon S., Yahalom R., and Regev E. Osteomylelitis and necrosis of the jaw in patients treated with bisphosphonates: a comparative study focused on multiple myeloma. Clin Lab Haematol 28 (2006) 393-398
11. Dimitrakopoulos I., Magopoulos C., and Karakasis D. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases. Int J Oral Maxillofac Surg 35 (2006) 588-593
12. Bamias A., Kastritis E., Bamia C., Moulopoulos L.A., Melakopoulos I., Bozas G., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23 (2005) 8580-8587
13. Abu-Id M.H., Acil Y., Gottschalk J., and Kreusch T. Bisphosphonate-associated osteonecrosis of the jaw. Mund Kiefer Gesichtschir 10 (2006) 73-81
14. Hellstein J.W., and Marek C.L. Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?. J Oral Maxillofac Surg 63 (2005) 682-689
15. Hellstein J.W., and Marek C.L. Bisphosphonate induced osteochemonecrosis of the jaws: an ounce of prevention may be worth a pound of cure. Spec Care Dentist 26 (2006) 8-12
16. Kademani D., Koka S., Lacy M.Q., and Rajkumar S.V. Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy. Mayo Clin Proc 81 (2006) 1100-1103
17. Leite A.F., Figueiredo P.T., Melo N.S., Acevedo A.C., Cavalcanti M.G., Paula L.M., et al. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 14-21
18. Lenz J.H., Steiner-Krammer B., Schmidt W., Fietkau R., Mueller P.C., and Gundlach K.K. Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?. J Craniomaxillofac Surg 33 (2005) 395-403
19. Ruggiero S.L., Mehrotra B., Rosenberg T.J., and Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527-534
20. Vescovi P., Merigo E., Meleti M., and Manfredi M. Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possible treatment?. J Oral Maxillofac Surg 64 (2006) 1460-1462
21. Merkesteyn van J.P.R., Groot R.H., Akker van den H.P., Bakker D.J., and Borgmeijer-Hoelen A.M.M.J. Treatment of chronic suppurative osteomyelitis of the mandible. Int J Oral Maxillofac Surg 26 (1997) 450-454
22. Dannemann C., Zwahlen R., and Gratz K.W. Clinical experiences with bisphopsphonate induced osteochemonecrosis of the jaws. Swiss Med Wkly 136 (2006) 504-509
23. Hansen T., Kunkel M., Weber A., and James Kirkpatrick C. Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35 (2006) 155-160